Finance

Beta
Lists
VRAX:NASDAQ
Virax Biolabs Group Ltd
$3.11
-7.85%
(-0.27) 1D
$3.41
+9.65% (+0.30)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRAX...
Open
$3.21
High
$4.75
Low
$2.75
Mkt. cap
59.75M
Avg. vol.
1.44M
Volume
675.93K
52-wk high
$28.50
52-wk low
$2.50
EPS
-$1.25
Beta
1.26
Shares outstanding
19.92M
No. of employees
19
Open
$3.21
High
$4.75
Low
$2.75
Mkt. cap
59.75M
Avg. vol.
1.44M
Volume
675.93K
52-wk high
$28.50
52-wk low
$2.50
EPS
-$1.25
Beta
1.26
Shares outstanding
19.92M
No. of employees
19
News stories
From sources across the web
About Virax Biolabs Group Ltd
CEO-
Employees19
Founded2013
HeadquartersLondon, England, United Kingdom
SectorHealth care provider
Websiteviraxbiolabs.com
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$1.00
-67.8%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
689.00
689.00
804.00
804.00
Cost of goods sold
23.98K
23.98K
161.00
161.00
Cost of revenue
23.98K
23.98K
161.00
161.00
Research and development expenses
526.70K
526.70K
689.87K
689.87K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.09M
1.09M
603.51K
603.51K
Operating expense
1.62M
1.62M
1.29M
1.29M
Total operating expenses
1.64M
1.64M
1.29M
1.29M
Operating income
-1.64M
-1.64M
-1.29M
-1.29M
Other non operating income
2.96K
2.96K
-201.00
-201.00
EBT including unusual items
-1.66M
-1.66M
-1.31M
-1.31M
EBT excluding unusual items
-1.66M
-1.66M
-1.31M
-1.31M
Income tax expense
-
-
-136.80K
-136.80K
Effective tax rate
-
-
10.46%
10.46%
Other operating expenses
-
-
-
-
Net income
-1.65M
-1.65M
-1.17M
-1.17M
Net profit margin
-239,827.29%
-239,827.29%
-145,446.02%
-145,446.02%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-16.29K
-16.29K
-15.50K
-15.50K
Net interest expenses
-16.29K
-16.29K
-15.50K
-15.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.57M
-1.57M
-1.21M
-1.21M
Gain or loss from assets sale
-
-
213.00
213.00
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VRAX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer